Companies / BOC Sciences / Patritumab
BOC Sciences

Patritumab | BOC Sciences

Patritumab is a human monoclonal antibody that targets HER3 and promotes receptor internalization, leading to the inhibition of basal and ligand-induced HER3 activation and downstream signaling.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.